The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'll be honest and say I very, very nearly bought shares today during the meeting. Not because I believed a word they were saying but because the talk was strong enough to likely convince some that this is a bargain and to therefore see a share price rise.
If you ask me their tactic is a straight forward fake it til you make it, aiming to boost the share price through this quarter and then raising as much as possible through a placing. That will give them one last bite at the cherry to make a success of this.
Optrade.......so it didnt "rocket" or go red.
Your a prize clown.
How long are you invested here?
Well, if you get a 100% rise from here, that will still leave you short of where the SP was in late February.
200% rise will still be well short of where the SP was, even in mid February.
Oh, and if you listen carefully to the recording, you will detect how cautious the CFO is about the cash runway.
Nothing wrong with that in itself of course - but listen to the words that he uses. Does he sound like someone who feels supremely confident that they have ample room to manage costs until that break even point? IMO, he absolutely does not.
Even more telling IMO, was how Greg answered the question of whether the Directors were planning on buying shares. If you have not seen it already, it is worth the admission alone :)
We all have to draw our own conclusions of course, but if you have listened to this one and previous ones, on top of reading all the RNS's over the past couple of years, and still feel bullish, well, your money, your choice. GLA, over and out.
If Greg is right the SP will be up 200% or more in 14 months; the next 1.25 P gain (100%) could happen well before or very soon. Sure, there is a risk but most of the worries are priced in. You need to be in to win.
They can all talk the talk, spin the spin but time will tell. They have as Harchris says told us all about Hardman research and lead us up the garden path. I've 2million of these at the wrong price & just glad today wasn't a total wipout but we are far far away from being out if the woods, but hey hoo, cash flow positive in H2 2025 apparently.....yes cash flow positive in H2 2025, I think he said H2 2025, correct me if I'm wrong but I do believe I heard both of them say H2 2025 but now my mind playing tricks with me. Was it H2 2025......that remains to be seen.....14 +months to wait
Cya later I hope you guys don't regret it. it's about to go blue :)
Usual blah bah which in the circumstances is gobsmacking. I've sold out here over the past weeks taking a proper kick in the you know whats on the way.
I'm off now down to the bookies to put what's left on the rank outsider in the 3.30 at Haydock. I have a far better chance there than with this pos.
Anyone who still believes Greg's words, after all this time, after the historic performance to date, all the irregularities, after all the times he has failed to buy shares from his own pocket, even....well, it is going to be difficult to feel sorry for them, in the event this goes the way some of us think it ultimately will.
But time will tell, as it always does. GLA. Except the BOD.
Certainly an interesting IMC.
If you were to believe Greg's words then this is the mother of all opportunities but the facts don't back it up. He also went on to answer my question by saying that they can't speak for the analysts guidance yet previously they were RNS'ing Hardman Research broker notes to the market and encouraging us all to read. I find his comments on how happy they are with the current growth trajectory to be downright disingenuous.
Greg continually claimed Shield can reach cash flow break even in H2 2025 without further funding, I call BS. I will watch with interest and will happily eat my hat, feathers and all, if proved wrong.
Once the market wakes up....catch a grip man.
Greg since arrival has presided over failure after failure. The goal posts keep getting moved and just expect another fund raise its probably priced in.
330k scripts in 2024,.....28.8k isn't actually a great start. If they get anywhere close to half that by year end it will be wonderful. However I doubt even that.
If good news is a 1% rise Q on Q I'd hate to see what bad news is.
GLA, ADYOR
Its online - webinar.
Nope, I do not attend shareholders meetings, too much travel and long days from Lincs.
Quote "Additionally, our stated initiatives to improve the average net selling price by increasing PA submission rates and more favorable Medicaid pricing following renegotiation of payer contracts, are progressing very well."
At this stage, they have successfully extended their financing and got improved terms on its existing $20 million debt financing with SWK Funding.
Let us know how it goes, still hoping for a blue day :)
Optrade, will you be attending today's investor meet ?
I will be for sure, want to see what their plans are to generate more revenue
Your Quote "The only thing going for you is that the value is low enough already that it might not crash further"
Yes, it's very undervalued, a good reason to BUY!
For your info, the results have been consistently strong and I don't see that there is anything in what you say will that stop it despite your built-up hate and dislike of the CEO.
Optrade last post from me as I don't want to upset you.
...But that couldn't be further from the truth. They did have sales momentum but it's totally lost. QoQ growth rate has dropped from 60% to 1% - that wouldn't be so bad if they were maturing at over 100k prescriptions per quarter but they are still only where they were meant to be last year before the full sales team had settled in.
The second key metric, net selling price, has also gone backwards this quarter too.
The only thing going for you is that the value is low enough already that it might not crash further, but there are now serious question marks around this management team and tbh, possibly even the product which is failing to gain traction.
GL, I hope this works out for you!
SMY, Shield is a small company with an experienced accountant who should control costs, their sales staff will be on high commissions. For what it's worth I don't care too much if they don't achieve the growth as fast as they want. They have a good product with a sales momentum that will be hard to stop so I believe they will continue to grow and be a profitable successful company.
I'm here for the long-term so it would be great it all the short-term negative posters move on without making things worse than what they are.
Optrade,
do you actually believe all the figures and the targets will be reached.?
They have been circa 50% of any target set previously so will it suddenly all change?
Good luck in your belief this will rocket today....lol
if it closes blue it will be fantastic
Why are you still here if you don't see anything positive in the results?
They are good enough to secure a large loan with no dilution of shares, once the market wakes up the SP is likely to bounce from these burnt-out low levels.
Are you joking?
Business Update and Audited Results April 2023 - Funded to support operations through to cash flow break-even by end of 2024
28th September 2023 - cash raise and new $20m debt facility
They are funded to cash flow break even if they totally reverse the course they are on, but that's completely unrealistic now. How they will go from 1% QoQ growth to nigh on 50% needs to be clearly explained by Greg later or it's simply bollo***
I dare to dream that your statement might come true. However I'm long enough here to realise that they burn through cash, do not have a great sales record across Europe, delays in China, Korea.
No mention in results about other parts of the world.
No dilution + Cash runway to breakeven + sales metrics improving
Most important bits
80%? I think you are being a bit too pessimistic actually.
But we seem to agree that today is likely to be a not insignificant red day :)
This is the time to BUY
ATL
Cashed up
Business moving forward
Recovery stock from here
27750 was the number of prescriptions they reported in Q3 of last year, before then downgrading it in q4.
So Shield are now at the level we all thought they were six months ago. Really poor. Was looking to buy in if there were any green shoots but it's tough to see where they go from here?